Search results for "elder"

showing 10 items of 919 documents

GOLD Staging System is Appropriate to Predict Mortality in Older People With Chronic Obstructive Pulmonary Disease

2018

Abstract Introduction In the new GOLD classification the reduction of FEV1, expressed as percentage of predicted value (FEV1PP), is considered an important prognostic factor. However, the use of FEV1PP may introduce bias, especially if based on equations derived from populations different from the one under study. We evaluated how well the GOLD classification stratifies the mortality risk when FEV1PP is based on an equation developed in the same population that gave rise to cases, externally developed equations, or as FEV1 divided by cubed height (FEV1/Ht3). Methods We studied 882 participants aged ≥65 years. Bronchial obstruction was defined using a fixed cut-off of 0.7 for FEV1/FVC. Predi…

BODE indexPulmonary and Respiratory Medicinemedicine.medical_specialtyPopulationPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesFEV1/FVC ratioFEV10302 clinical medicineElderlyInternal medicinemedicine030212 general & internal medicineGOLDeducationStaging systemCOPDeducation.field_of_studybusiness.industryChronic obstructive pulmonary diseaseHazard ratioGeneral Medicinerespiratory systemmedicine.diseaserespiratory tract diseases030228 respiratory systemQuartilebusiness
researchProduct

An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes.

2017

Background: Information about the impact of frailty in patients with acute coronary syndromes (ACS) is scarce. No study has assessed the prognostic impact of frailty as measured by the FRAIL scale in very elderly patients with ACS. Methods: The prospective multicenter LONGEVO-SCA registry included unselected patients with ACS aged 80 years or older. A comprehensive geriatric assessment was performed during hospitalization, including frailty assessment by the FRAIL scale. The primary endpoint was mortality at 6 months. Results: A total of 532 patients were included. Mean age was 84.3 years, 61.7% male. Most patients had positive troponin levels (84%) and high GRACE risk score values (mean 16…

Background informationMalemedicine.medical_specialtyTime FactorsFrail ElderlyEnfermedad cardiovascularAncianoComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineInternal medicineCause of DeathClinical endpointPrevalenceMedicineHumansIn patient030212 general & internal medicineProspective StudiesRegistriesAcute Coronary SyndromeGeneral NursingProportional Hazards ModelsAged 80 and overFramingham Risk ScoreEjection fractionbiologyFrailtybusiness.industryHealth PolicyMortality rateGeriatric assessmentGeneral MedicinePrognosisTroponinSurvival AnalysisSpainbiology.proteinCardiopatía coronariaFemaleGeriatrics and GerontologybusinessAncianosJournal of the American Medical Directors Association
researchProduct

Re: The Clinical Impact of Bacteremia on Outcomes in Elderly Patients with Pyelonephritis or Urinary Sepsis: A Prospective Multicenter Study

2018

Background Bacteremia is common in severe urinary infections, but its influence on the outcomes is not well established. The aim of this study was to assess the association of bacteremia with outcomes in elderly patients admitted to hospital with pyelonephritis or urinary sepsis. Methods This prospective muticenter observational study was conducted at 5 Spanish hospitals. All patients aged >65 years with pyelonephritis or urinary sepsis admitted to the departments of internal medicine and with urine and blood cultures obtained at admission to hospital were eligible. Transfer to ICU, length of hospital stay, hospital mortality and all cause 30-day mortality in bacteremic and non-bacteremic g…

Bacterial DiseasesMaleMultivariate analysisPhysiologylcsh:MedicineBacteremiaUrineUrinePathology and Laboratory MedicineElderly0302 clinical medicineMedicine and Health Sciences030212 general & internal medicineProspective Studieslcsh:ScienceProspective cohort studyAged 80 and overMultidisciplinaryPyelonephritisHospitalsBody FluidsInfectious DiseasesBloodCohortUrinary Tract InfectionsFemaleAnatomyResearch Articlemedicine.medical_specialtyUrologyUrinary systemMEDLINESepsis03 medical and health sciencesSigns and SymptomsDiagnostic MedicineSepsisInternal medicinemedicineHumansAgedSeptic shockbusiness.industrylcsh:RBiology and Life Sciencesmedicine.diseaseHealth Care030228 respiratory systemMulticenter studyHealth Care FacilitiesGeriatricsAge GroupsBacteremiaPeople and PlacesPopulation Groupingslcsh:QbusinessJournal of Urology
researchProduct

Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons

2017

The assessment of body composition has important applications in the evaluation of nutritional status and estimating potential health risks. Bioelectrical impedance analysis (BIA) is a valid method for the assessment of body composition. BIA is an alternative to more invasive and expensive methods like dual-energy X-ray absorptiometry, computerized tomography, and magnetic resonance imaging. Bioelectrical impedance analysis is an easy-to-use and low-cost method for the estimation of fat-free mass (FFM) in physiological and pathological conditions. The reliability of BIA measurements is influenced by various factors related to the instrument itself, including electrodes, operator, subject, a…

Bioelectrical impedance analysismedicine.medical_specialtyAgingNutritional Status030209 endocrinology & metabolismBody composition03 medical and health sciences0302 clinical medicineElderlyThinnessBioelectrical impedance analysis Body composition Elderly Prediction equationsStatisticsmedicineElectric ImpedanceHumans030212 general & internal medicineMuscle SkeletalMathematicsBioelectrical impedance analysis; Body composition; Elderly; Prediction equationsGeriatrics gerontologyReproducibility of ResultsRegression analysisNutritional statusPrediction equationsSkeletal muscle massSurgeryLean body massRegression AnalysisGeriatrics and GerontologyBioelectrical impedance analysis
researchProduct

Serum Dehydroepiandrosterone Sulfate and Risk for Type 2 Diabetes in Older Men and Women: The Pro.V.A Study

2016

Objective: A large body of clinical data suggests the importance of endogenous sex hormones in the pathogenesis of diabetes, but very little is known about the possible relationship between dehydroepiandrosterone sulfate (DHEAS) and diabetes, particularly in the elderly. We aimed, therefore, to examine whether high serum levels of DHEAS have any protective effects on the incidence of type 2 diabetes and to elucidate the possible role of gender in a cohort of older subjects. Methods: We followed 1258 community-dwelling subjects aged ≥65 years without type 2 diabetes who belonged to the Progetto Veneto Anziani (Pro.V.A.) for 4.4±1.2 years. DHEAS were measured at baseline and categorized into …

Blood GlucoseMale0301 basic medicinemedicine.medical_specialtyDHEASEndocrinology Diabetes and MetabolismBlood sugarPhysiology030209 endocrinology & metabolismType 2 diabetesNOsex hormones in the pathogenesis of diabeteCohort Studies03 medical and health scienceschemistry.chemical_compoundElderly0302 clinical medicineEndocrinologyDehydroepiandrosterone sulfateRisk FactorsInternal medicineDiabetes mellitusInternal MedicineHumansMedicineAgedGlycated HemoglobinDehydroepiandrosterone Sulfatebusiness.industryIncidence (epidemiology)Type 2 diabetesGeneral MedicinePrognosismedicine.diseaseCommunity-dwelling adultsDiabetes and Metabolism030104 developmental biologyEndocrinologyDiabetes Mellitus Type 2chemistrydehydroepiandrosterone sulfate (DHEAS)CohortCommunity-dwelling adults; DHEAS; Elderly; Type 2 diabetes; Internal Medicine; Endocrinology; Endocrinology Diabetes and MetabolismFemaleGlycated hemoglobinbusinessBiomarkersFollow-Up StudiesCohort studyCanadian Journal of Diabetes
researchProduct

Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and de…

2015

Abstract Objectives Severe hypoglycemia is associated with cognitive decline and dementia in older persons with type 2 diabetes. The role of antidiabetic treatments on severe hypoglycemia is unknown in dementia. The aims were to determine the prevalence of severe hypoglycemic events and investigate associations among severe hypoglycemic and specific antidiabetic treatments (classes of oral agents and types of insulin analogs) in a large sample of nursing home patients with diabetes according to dementia status. Design Cross-sectional observational study. Setting A total of 150 nursing homes across Italy. Participants A total of 2258 patients with type 2 diabetes (dementia = 1138, no dementi…

Blood GlucoseMaleAgingSevere hypoglycemia dementia insulin analogs antidiabetic oral agents agingmedicine.medical_treatmentInsulin analogAdministration OralType 2 diabetesSeverity of Illness IndexInsulin AntagonistsReference ValuesOdds RatioPrevalenceHomes for the AgedInsulinReference ValueCognitive declineNursing (all)2901 Nursing (miscellaneous)General NursingAged 80 and overInsulin AntagonistMedicine (all)Health PolicyAging; Antidiabetic oral agents; Dementia; Insulin analogs; Severe hypoglycemia; Administration Oral; Age Distribution; Aged; Aged 80 and over; Blood Glucose; Confidence Intervals; Cross-Sectional Studies; Dementia; Diabetes Mellitus Type 2; Female; Homes for the Aged; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Antagonists; Italy; Logistic Models; Male; Middle Aged; Nursing Homes; Odds Ratio; Prevalence; Prognosis; Reference Values; Risk Assessment; Severity of Illness Index; Sex Distribution; Sulfonylurea Compounds; Nursing (all)2901 Nursing (miscellaneous); Health PolicyGeneral MedicineMiddle AgedPrognosisSulfonylurea CompoundNursing HomeItalyFemaleHumanmedicine.medical_specialtyLogistic ModelPrognosiHypoglycemiaelderly patientsRisk AssessmentAge DistributionInternal medicineDiabetes mellitusmedicineConfidence IntervalsDementiaHumansHypoglycemic AgentsSex DistributionAgedAntidiabetic oral agentCross-Sectional StudieSevere hypoglycemiaHypoglycemic Agentbusiness.industryInsulinOdds ratiomedicine.diseaseHypoglycemiaNursing HomesEndocrinologyCross-Sectional StudiesLogistic ModelsSulfonylurea CompoundsDiabetes Mellitus Type 2DementiaGeriatrics and GerontologybusinessConfidence IntervalBody mass indexJournal of the American Medical Directors Association
researchProduct

Le cancer du sein de la femme agée.

1992

Breast cancer elderly women
researchProduct

Odontoiatria di genere: la condizione femminile nella pratica odontoiatrica

2014

Obiettivi: scopo del presente studio è quello di esaminare la condizione femminile in relazione alla professione odontoiatrica, quelle condizioni patologiche orali che possono colpire in particolare il sesso femminile e i trattamenti relativi. Materiali e metodi: oltre alla propria esperienza e al contributo personale, sono state effettuate ricerche sui motori di ricerca scientifica PubMed, Embase e Scopus. Risultati e conclusioni: è stata esaminata la figura della odontoiatra donna e la sua collocazione nell'ambito professionale, nonché le sue caratteristiche lavorative sia in relazione ai pazienti sia in relazione alla propria famiglia. Sono state analizzate poi le più comuni condizioni p…

Breast-feedingElder ageFemale genderPregnancymedia_common.quotation_subjectOrthodonticsArtOral SurgeryBreast feedingHumanitiesDental professionmedia_common
researchProduct

Concealed renal failure in COPD. The extrapulmonary consequences of COPD in the elderly (ECCE) study

2009

COPD elderlySettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Non-pegylated liposomal doxorubicin plus cyclophosphamide as first-line therapy in elderly women with HER2 negative metastatic breast cancer.

2022

Background. The use of anthracyclines in metastatic breast cancer (MBC) is limited by cumulative dose-dependent cardiotoxicity mostly in elderly women with comorbidities. The aim of this observational retrospective study was to evaluate the efficacy of non-pegylated liposomal doxorubicin (Myocet®) and cyclophosphamide in elderly women as HER2 negative first-line MBC treatment. Methods. 84 elderly women >70 years of age (median age 78 years) with MBC HER2 negative were enrolled. Performance Status in 58 patients was ECOG-0 and in 26 patients was ECOG-1. Results. The drug was well tolerated, with overall response rates were >40%, median overall survival was 16.2 months (95%CI:14.6- 18.8…

Ca 15-3 Cyclophosphamide Elderly woman Metastatic breast cancer Non-pegylated liposomal doxorubicin Quality of lifeTreatment OutcomeDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsHumansBreast NeoplasmsFemaleCyclophosphamideCardiotoxicityAgedPolyethylene GlycolsRetrospective StudiesLa Clinica terapeutica
researchProduct